Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMAC for Critical Limb Ischemia in Type 2 Diabetes
NCT01818310Phase 3Completed
- Sponsor
- University Hospital Ostrava
- Start
- Sep 2012
- Primary completion
- Sep 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous bone marrow cell concentrate in critical limb ischemia (CLI), sponsored by University Hospital Ostrava. Started Sep 2012; status: completed.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT01818310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01818310.